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Objectives: AmpC beta-lactamases are clinically important
cephalosporinases that confer resistance to wide variety of
beta-lactam drugs, which result in considerable treatment fail-
ure and cannot be detected by routine antibiotic sensitivity
screening methods. Research was designed to estimate emer-
gence of AmpC beta-lactamase (AmpC) producing strains among
multi-drug resistant (MDR) urinary tract isolates in Nepal.
Methods: 2837 urine samples were obtained for culture from
clinically suspected urinary tract infection (UTI) patients from
July, 2005 to March, 2007. Isolates were tested to detect antibi-
otic susceptibility. MDR gram negative isolates were screened for
AmpC producers by modiﬁed double disk approximation method
(MDMM) and conﬁrmed by three dimensional extract method
as described by American Society for Microbiology (ASM) and
National Committee for Clinical Laboratory Standard (NCCLS).
Results: Among 2837 urine samples, 31.4% (891/2837) had signiﬁ-
cant bacterial growth with 825 (92.6%) non-repeat gram-negative
isolates. Out of gram-negative isolates 67.1% (554/825) were
MDR. 5.41% (30/554) of MDR were AmpC positive. Among Indi-
vidual MDR isolates species, 6.1% E. coli, 8.33% Klebsiella, 3.12%
Pseudomonas and 4.0% Proteus were AmpC producing.
Conclusion: These data conﬁrm that AmpC is emerging cause of
MDR in Nepal. We need to subject these strains for genetic study
to acquire genetic make up. Failure to detect AmpC can con-
tribute their uncontrolled nosocomial transmission, therapeutic
failures and increased cost of management. Our results suggest
to start screening of AmpC among MDR gram negative isolates
in routine hospital practices in order to guide the choice of
empirical therapy for such infections.
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Objectives: To investigate the antibacterial and phytochemical
properties of the seeds coat of Detarium microcarpum.
Methods: Extraction was by exhaustive cold maceration in 90%
aqueous methanol. Silica gel 60G TLC separation done with
Butan-2-one: chloroform: acetic acid: water (40:40:2:1v/v) as
mobile phase. Bands were visualised in daylight and UV light.
Band B1 was further puriﬁed by precipitating with acetone
to obtain the acetone soluble AS and insoluble AP isolates.
Phytochemistry was by using standard phytochemical screening
reagents, and UV spectroscopy. Antibacterial screening was by
the agar diffusion method.
Results: On TLC, the ES fraction gave eight constituents B1
(Rf=0.000), B2 (Rf=0.079), B3 (Rf=0.250), B4 (Rf=0.286), B5
(Rf=0.500), B6 (Rf=0.686), B7 (Rf=0.814), and B8 (Rf=1.000). B1
retained the antibacterial activity spectrum, B2 and B3 showed
residual inhibition against B. subtilis, B4-B8 were inactive. The
AS isolate form B1 exhibited a higher activity than the AP iso-
late. From phytochemistry, B1 contained steroidal saponins and
ﬂavonoid, AP steroidal saponins, AS, B2 and B3 are ﬂavonoids.
B2 and B3 revealed the characteristic benzopyrone maxima
(236nm-300nm). Against the selected bacteria, MIC range of
0.9053-3.5801mg/ml was observed.
Conclusion: This study revealed the antibacterial principles in
the seed coat of D. microcarpum to be steroidal saponins and
ﬂavonoids with synergistic possibilities, and the lead optimisation
potentials of phytoalexins in the seed coats of edible legumes.
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Dept. of Infectious Diseases, First Hospital Jilin University
Background: The prevalence of brucellosis is increasing in China
over the past several years. The purpose of this study was to
investigate whether the sika deer serves as a source of human
infection by brucella in Jilin Province of Northeast China.
Methods: Brucellosis was diagnosed in 57 patients during the
periods from June 2007 through December 2008 in our hospital.
The sources of infection and routes of transmission were investi-
gated. Blood samples from these patients and 6 sika deer were
obtained for Brucella antibody testing and culturing bacteria.
Results: Of the 57 patients, 3 (1 man and 2 women) were sika
deer breeders. They were from two families, and each family
has a herd of approximately 60 sika deer. They observed several
abortions in their deer before they were sick. All 3 patients had
prolonged intermittent fevers, night sweats, body aches, arthral-
gias, and weakness. Blood samples from these patients were
negative for brucella culture, but positive for brucella antibodies
in the agglutination test. In the 6 relevant sika deer (3 males and
3 females) examined, 1 presented with orchitis, 1 had right knee
arthritis, and 1 showed progress body weight loss. However, all 6
sika deer were positive for brucella antibodies as determined by
an agglutination test, and 1 of them was also positive for brucella
bovis in the blood culture.
Conclusion: Sika deer can be infected with Brucella bovis, and
serve as a bacteria reservoir and transmit the infection to human
in Northeast China.
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Background: The burn wound represents a site susceptible
to colonization of opportunistic pathogens, e.g. Pseudomonas
aeruginosa. This study was planning to investigate drug suscepti-
bility and routes of transmission by molecular epidemiology in P.
aeruginosa isolated in a Burn unit.
Methods: To study the drug susceptibility and molecular epi-
demiology of P. aeruginosa colonization in the burn unit of Shahid
Motahhari Hospital (Tehran), 127 clinical and 2 environmental
P. aeruginosa isolates were collected during 6 months. All P.
aeruginosa isolates were analyzed for drug susceptibility by disk
diffusion method and molecular epidemiology assessment were
done by random ampliﬁed polymorphic DNA (RAPD) analysis.
Results: Drug susceptibility tests were shown high resistance for
ceftizoxime (86.8%), aztreonam (80.6%), kanamycin (79.8%),
tetracycline (78.3%), and ceftazidime (75.2%), furthermore,
high susceptibility for some antibiotics like imipenem (69.8%),
piperacillin/tazobactam (65.9%), and amikacin (58.9%) was
showed. In this study, 42 multidrug-resistant (MDR) P. aerugi-
nosa isolates were recovered from clinical specimens and also,
one isolate was recovered from environment. Molecular typing
revealed eight different proﬁles that include two proﬁles, RAPD1
